ASML vs BELFA

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.

BELFA's Advanced Deterministic Scorecard reveals weak financial health with a Piotroski F-Score of 3/9, indicating significant concerns in profitability, leverage, and operating efficiency. Despite this, the company exhibits strong recent growth, with 44.80% YoY revenue growth and 172.90% earnings growth, supported by consistent earnings beats and high profitability margins. Valuation appears stretched at a P/E of 37.63 versus a Graham Number of $60.47, though sector context (avg P/E 93.05) suggests relative reasonableness. The lack of Altman Z-Score and analyst coverage, combined with weak insider sentiment and deteriorating technical trend, offsets strong fundamentals and growth momentum.